Ingenium Therapeutics announced that it has received KRW 5.3 billion in funding from Laplace Partners Inc., Capstone Partners Co., Ltd., KGROUND Ventures LLC and another investor.

Ingenium Therapeutics announced that it has raised KRW 5,300 million in a round of funding on November 21, 2023. The transaction included participation from new investors Capstone Partners Co., Ltd.,KGROUND Ventures LLC,Laplace Partners Inc. and Daewoodang Healthcare.